Go here to see the original: Cresemba® sales in Latin America trigger first sales milestone payment to Basilea
Go here to see the original: Cresemba® sales in Latin America trigger first sales milestone payment to Basilea
View post: United States Food & Drug Administration (FDA) Grants Mesoblast Rare Pediatric Disease Designation for Revascor® (Rexlemestrocel-L) in Children...
Here is the original post: ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024
Here is the original post: ORYZON to Host KOL Event on Phase IIb PORTICO Topline Study Results of Vafidemstat in Borderline Personality Disorder on January 25, 2024
See more here: Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast Cancer
Follow this link: Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
See the original post here: Novartis Lutathera® significantly reduced risk of disease progression or death by 72% as first-line treatment for patients with advanced...
See more here: Zealand Pharma major shareholder announcement: J O Hambro Capital Management
Follow this link: Change of management at NTG Nordic Transport Group A/S
Recent Comments